Royal Bank Of Canada Halozyme Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 521,023 shares of HALO stock, worth $25.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

521,023

Previous 479,932 8.56%

Holding current value

$25.5 Million

Previous $25.1 Million 18.62%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $2.11 Million - $2.65 Million	41,091 Added 8.56%	521,023 $29.8 Million
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $405,814 - $562,409	-10,733 Reduced 2.19%	479,932 $25.1 Million
Q1 2024 Nov 05, 2024	BUY	$33.68 - $41.95 $361,487 - $450,249	10,733 Added 2.24%	490,665 $20 Million
Q1 2024 May 15, 2024	SELL	$33.68 - $41.95 $304,332 - $379,060	-9,036 Reduced 1.81%	490,665 $20 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $581,600 - $734,855	17,455 Added 3.62%	499,701 $18.5 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $1.18 Million - $1.42 Million	-32,301 Reduced 6.28%	482,246 $18.4 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $321,603 - $411,457	10,621 Added 2.11%	514,547 $18.6 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $4.12 Million - $6.99 Million	125,460 Added 33.15%	503,926 $19.2 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $1.9 Million - $2.82 Million	-47,486 Reduced 11.15%	378,466 $21.5 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $15.5 Million - $20.8 Million	401,225 Added 1622.62%	425,952 $16.8 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $368,046 - $475,948	9,854 Added 66.25%	24,727 $1.09 Million
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $803,629 - $1.03 Million	-25,137 Reduced 62.83%	14,873 $593,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $38,438 - $49,226	1,208 Added 3.11%	40,010 $1.61 Million
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $78,671 - $94,928	-2,045 Reduced 5.01%	38,802 $1.58 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $1.59 Million - $2.1 Million	40,847 New	40,847 $1.86 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Halozyme Therapeutics, Inc. Transaction History